Table of Contents Table of Contents
Previous Page  10 / 238 Next Page
Information
Show Menu
Previous Page 10 / 238 Next Page
Page Background

10

29

th

CONGRESS OF THE ESPU

S1: BASIC RESEARCH 1

Moderators: Yazan Rawashdeh (Denmark), Christian Radmayr (Austria)

ESPU Meeting on Wednesday 11, April 2018, 13:30–15:00

13:30–13:33

S1-1 (PP)

HISTOLOGIC FEATURES OF THE EXSTROPHIC BLADDER

BEFORE AND AFTER DELAYED PRIMARY REPAIR:

RESULTS OF AN ONGOING PROSPECTIVE STUDY

Peter RUBENWOLF 

1

, Fabian EDER 

2

, Stefanie GOETZ 

3

, Anne-Karoline EBERT 

4

and

Wolfgang H. ROESCH 

4

1) University Hospital Frankfurt, Urology, Frankfurt, GERMANY - 2) University Hospital Regensburg, Pathology,

Regensburg, GERMANY - 3) University Hospital Regensburg, Urology, Regensburg, GERMANY - 4) University Hospital

Regensburg, Pediatric Urology, Regensburg, GERMANY

PURPOSE

To investigate the exstrophic bladder at the time of primary bladder closure and subsequently during

secondary procedures in view of histologic alterations and discuss the findings in terms of potential

clinical implications.

MATERIAL AND METHODS

At least 2 bladder biospies from patients with classic BE were obtained a) at the time of delayed

primary repair, b) during secondary reconstructive procedures and c) during subtotal cystectomy for

failed reconstruction. Specimens were examined by a uropathologist for edema, fibrosis, inflamma-

tory, metaplastic and proliferative changes.

RESULTS

As yet bladder specimens from 97 patients (mean age 6,4, range: 0,11–25 years) were analysed.

Edema, fibrosis, inflammatory and proliferative changes were observed in all 3 groups. Dysplastic

or malignant changes were not present. Detailed results are shown in Table 1.

GROUP/Number of pts/ mean age

Histologic feature (%)

A - Primary

delayed closure

n=45; 0,17 yrs.

B - Secondary

procedures

n=37; 7,8 yrs

C - Cystectomy

(failed reconstruction)

n=15; 11,1 yrs

Edema

55

40

20

Fibrosis

48

69

73

Inflammation

95

43

80

Squamous metaplasia

80

43

73

Cystitis cystica/glandularis

83

57

87

Intestinal metaplasia

0

14

53

Dysplasia/malignant neoplasia

0

0

0